Skip to main content
Figure 3 | Allergy, Asthma & Clinical Immunology

Figure 3

From: Chitosan Interferon-γ Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses

Figure 3

Effect of chitosan interferon-γ nanogene (CIN) therapy on the dendritic cell population in the lung. Ovalbumin-allergic/-challenged mice were treated with or without CIN therapy as described in Materials and Methods, and mononuclear cells were isolated from the lungs. Cells were stained with fluorescein isothiocyanate (FITC)-anti-CD11c and rhodamine (Rhod)-anti-CD11b, and CD11c+b+ cells were counted by flow cytometry. Values given are the percentage of total CD11c+ cells that are also CD11b+. The data are based on cytometry of a minimum of 15,000 cells and were substantiated by a repeat experiment.

Back to article page